Clinical effects of lentinan combined with budesonide inhalation in treating acute exacerbation of chronic obstructive pulmonary disease under mechanical ventilation

Sun,Jian; Zhao,Gang

doi:10.3892/etm.2019.7149

Clinical effects of lentinan combined with budesonide inhalation in treating acute exacerbation of chronic obstructive pulmonary disease under mechanical ventilation

Authors:
- Jian Sun
- Gang Zhao
View Affiliations

Affiliations: Department of Emergency, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, P.R. China
Published online on: January 3, 2019 https://doi.org/10.3892/etm.2019.7149
Pages: 1503-1508
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, the clinical efficacy of the immune modulator lentinan combined with inhalation of the corticosteroid budesonide in treating acute exacerbation of chronic obstructive pulmonary disease (AECOPD) under mechanical ventilation was assessed. A total of 72 cases of AECOPD treated at Shanghai Jiao Tong University Affiliated Sixth People's Hospital (Shanghai, China) between June 2016 and September 2017 were enrolled. The AECOPD patients were randomly divided into an experimental group (n=36) and a control group (n=36). All of the patients received ventilator support and endotracheal intubation was performed. The experimental group was orally administered lentinan and budesonide was administered via atomization inhalation through a Y‑tube and the control group received only budesonide via Y‑tube. After the treatment, airway pressure, the time of mechanical ventilation and the time of stay at the intensive care unit for the experimental group were significantly lower than those for the control group (P<0.001). The plasma levels of adiponectin, D‑dimer, interleukin‑17 and high‑sensitivity C‑reactive protein, as well as the pressure of CO2 in the experimental group were significantly lower than those in control group (P<0.001). Furthermore, the partial O2 pressure in the experimental group was significantly higher than that in the control group (P<0.001). After the combined treatment, the proportions of CD3+ and CD4+T‑cells in the blood were elevated, while the proportion of CD8+T‑cells was decreased, compared with those in the experimental group at baseline or the control group post‑treatment. In conclusion, the strategy of lentinan treatment combined with budesonide inhalation for AECOPD patients under mechanical ventilation demonstrated improved clinical efficacy compared with budesonide alone. (Chinese Clinical Trial Registry no. ChiCTR1800019088).

View Figures

View References

1	Spyratos D and Sichletidis L: Umeclidinium bromide/vilanterol combination in the treatment of chronic obstructive pulmonary disease: A review. Ther Clin Risk Manag. 11:481–487. 2015.PubMed/NCBI
2	Zhong J and Roth M: Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease. Ther Clin Risk Manag. 10:449–453. 2014.PubMed/NCBI
3	Vitacca M, Bianchi L, Bazza A and Clini EM: Advanced COPD patients under home mechanical ventilation and/or long term oxygen therapy: Italian healthcare costs. Monaldi Arch Chest Dis. 75:207–214. 2011.PubMed/NCBI
4	Faenza S and Petrini F: Mechanical ventilation in the emergency room. Minerva Anestesiol. 66:883–887. 2000.(In Italian). PubMed/NCBI
5	Brijker F, van den Elshout FJ, de Rijk A, Folgering HT and Bosch FH: Use of noninvasive mechanical ventilation to avoid intubation during acute respiratory insufficiency. Ned Tijdschr Geneeskd. 143:1819–1823. 1999.(In Dutch). PubMed/NCBI
6	Hashemian SM, Mortaz E, Jamaati H, Bagheri L, Mohajerani SA, Garssen J, Movassaghi M, Barnes PJ, Hill NS and Adcock IM: Budesonide facilitates weaning from mechanical ventilation in difficult-to-wean very severe COPD patients: Association with inflammatory mediators and cells. J Crit Care. 44:161–167. 2018. View Article : Google Scholar : PubMed/NCBI
7	Dixit D, Bridgeman MB, Andrews LB, Narayanan N, Radbel J, Parikh A and Sunderram J: Acute exacerbations of chronic obstructive pulmonary disease: Diagnosis, management, and prevention in critically ill patients. Pharmacotherapy. 35:631–648. 2015. View Article : Google Scholar : PubMed/NCBI
8	Liu YH, Ma SD, Fu QJ, Zhao LY, Li Y, Wang HQ and Li MC: Effect of lentinan on membrane-bound protein expression in splenic lymphocytes under chronic low-dose radiation. Int Immunopharmacol. 22:505–514. 2014. View Article : Google Scholar : PubMed/NCBI
9	Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, Rouleau M, Boukhana M, Martinot JB and Duroux P: Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial. Am J Respir Crit Care Med. 165:698–703. 2002. View Article : Google Scholar : PubMed/NCBI
10	Ma Z and Zhang W: Short-term versus longer duration of glucocorticoid therapy for exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 40:84–90. 2016. View Article : Google Scholar : PubMed/NCBI
11	Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch Bronconeumol. 53:128–149. 2017.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
12	Rudan I, Campbell H, Marušić A, Sridhar D, Nair H, Adeloye D, Theodoratou E and Chan KY: Assembling GHERG: Could ‘academic crowd-sourcing’ address gaps in global health estimates? J Glob Health. 5:0101012015. View Article : Google Scholar : PubMed/NCBI
13	Uren NG, Davies SW, Jordan SL and Lipkin DP: Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure. Eur Heart J. 14:744–750. 1993. View Article : Google Scholar : PubMed/NCBI
14	Yalçınsoy M, Salturk C, Takır HB, Kutlu SB, Oguz A, Aksoy E, Balcı M, Kargın F, Mocin OY, Adıguzel N, et al: Case fatality rate related to nosocomial and ventilator-associated pneumonia in an ICU: A single-centre retrospective cohort study. Wien Klin Wochenschr. 128:95–101. 2016. View Article : Google Scholar : PubMed/NCBI
15	Boixeda R, Bacca S, Elias L, Capdevila JA, Vilà X, Mauri M and Almirall J: Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between acute exacerbation of COPD and pneumonia in patients with COPD. Arch Bronconeumol. 50:514–520. 2014.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI
16	McCurdy BR: Noninvasive positive pressure ventilation for acute respiratory failure patients with chronic obstructive pulmonary disease (COPD): An evidence-based analysis. Ont Health Technol Assess Ser. 12:1–102. 2012.
17	Xiong G, Xu L, Wei L and Li X: Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients. Cell Mol Immunol. 5:287–291. 2008. View Article : Google Scholar : PubMed/NCBI
18	Leivo-Korpela S, Lehtimäki L, Vuolteenaho K, Nieminen R, Kööbi L, Järvenpää R, Kankaanranta H, Saarelainen S and Moilanen E: Adiponectin is associated with dynamic hyperinflation and a favourable response to inhaled glucocorticoids in patients with COPD. Respir Med. 108:122–128. 2014. View Article : Google Scholar : PubMed/NCBI
19	Kirdar S, Serter M, Ceylan E, Sener AG, Kavak T and Karadağ F: Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest. 69:219–224. 2009. View Article : Google Scholar : PubMed/NCBI
20	Zhang M, Zhang J, Zhang Q, Yang X, Shan H, Ming Z, Chen H, Liu Y, Yin J and Li Y: D-dimer as a potential biomarker for the progression of COPD. Clin Chim Acta. 455:55–59. 2016. View Article : Google Scholar : PubMed/NCBI
21	Beringer A, Noack M and Miossec P: IL-17 in Chronic Inflammation: From Discovery to Targeting. Trends Mol Med. 22:230–241. 2016. View Article : Google Scholar : PubMed/NCBI
22	Cai BQ, Cai SX, Chen RC, et al: Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China. Int J Chron Obstruct Pulmon Dis. 9:381–95. 2014.PubMed/NCBI